BL
ENZ

BFSG LLC’s Enzo Biochem, Inc. ENZ Stock Holding History

BFSG LLC’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000
Closed -$1.43K – 719
2024
Q4 		$1.43K Sell
2,000
-813
-29% -$843 ﹤0.01% 622
2024
Q3 		$3.15K Hold
2,813
– – ﹤0.01% 566
2024
Q2 		$3.07K Hold
2,813
– – ﹤0.01% 552
2024
Q1 		$3.57K Buy
+2,813
New +$3.71K ﹤0.01% 564

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFSG LLC's ENZ Position: Q1 2025 in Review

BFSG LLC sold out of Enzo Biochem, Inc. (ENZ) in Q1 2025, closing a stake of 2,000 shares — an estimated $1.43K sold.

BFSG LLC first reported a position in ENZ in Q1 2024 and held it in 4 quarters. The position peaked at $3.57K in Q1 2024. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2025.

  • BFSG LLC reported no remaining Enzo Biochem, Inc. position as of Q1 2025 after selling out during the quarter.
  • BFSG LLC sold 2,000 Enzo Biochem, Inc. shares in Q1 2025, an estimated $1.43K.
  • BFSG LLC first reported a position in Enzo Biochem, Inc. in Q1 2024 and held it in 4 quarters.
  • BFSG LLC's Enzo Biochem, Inc. position peaked at $3.57K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2025.

Based on BFSG LLC's 13F filing for Q1 2025, filed 18 Apr 2025.